key: cord-0755568-teisk4an
authors: Glikman, Daniel; Stein, Michal; Shinwell, Eric S.
title: Vaccinating children and adolescents against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)—The Israeli experience
date: 2021-06-22
journal: Acta Paediatr
DOI: 10.1111/apa.15982
sha: d094c63dd632f7673f39beecf92ddfe002777124
doc_id: 755568
cord_uid: teisk4an

nan

were vaccinated with at least one dose, while by May 2021, 54%

were already fully vaccinated. Accordingly, the daily number of new COVID-19 cases in Israel has declined from 10 000 at the peak of the third wave in January 2021 to less than 100 in May this year. 1 SARS-CoV-2 infects all ages. Although childhood morbidity rates are low compared with their relative proportion of the population, severe cases, the need for admission to the paediatric intensive care unit (PICU) and mortality have been reported worldwide. 2 Additionally, since April 2020, a novel hyperinflammatory condition with severe multisystem involvement has been described in children and adolescents, typically 2-4 weeks after SARS-CoV-2 infection, and named paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) or multisystem inflammatory syndrome in children (MIS-C). 3 As regards children, Israel is a country with a young population, At the beginning of the COVID-19 pandemic, some expert opinions and hopeful thinking leaned towards a rapid termination of the pandemic with the disappearance of the virus, similar to SARS-CoV-1. Almost a year and a half later, it seems the virus is here to stay, either in the current wave dynamics or in the seasonal epidemics, similar to the influenza virus and the respiratory syncytial virus.

In our opinion, vaccinating children and adolescents against SARS-CoV-2 is the way to go forward to reduce COVID-19 morbidity and mortality, as an ounce of prevention is worth a pound of cure. 

Risk factors for severity in children with coronavirus disease 2019: a comprehensive literature review

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Israeli ministry of health data

COVID-19 in a subset of hospitalized children in Israel

The effects of social deprivation on adolescent development and social health

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine

BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting

First month of COVID-19 vaccine safety monitoring -United States

Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine